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ABSTRACT  
 
Purpose: The molecular pathogenesis of gastroenteropancreatic endocrine tumors (ETs) is still largely 
unknown. The purpose of this work was a molecular characterization of 38 gastroenteropancreatic ETs with 
respect to the primary site and to the morphofunctional profile, pointing out useful diagnostic or 
prognostic molecular markers. 
Experimental Design: Twenty-four well-differentiated ETs or carcinomas (WDET/Cs; 11 pancreatic, 3 
gastric, and 10 intestinal) and 14 poorly differentiated endocrine carcinomas (1 pancreatic, 6 gastric, and 7 
colorectal) were microallelotyped using 38 polymorphic microsatellite markers covering chromosomes 1, 3, 
5q, 6, 11, 17, and 18. 
Results: Regardless of the primary site, a significantly higher percentage of allelic imbalances (AIs) was 
observed in poorly differentiated endocrine carcinomas than in WDET/Cs (P _ 0.012), except for 3 of 8 
nonfunctioning pancreatic endocrine tumors and 1 colorectal WDEC, exhibiting multiple AIs on  
chromosomes 1, 3, 6, and 11. A strong positive correlation between AI percentage and Ki-67 
proliferation index was detected considering both the whole series of ETs (P _ 0.004) and the group of 
WDET/Cs alone (P _ 0.011). The survival analysis showed a positive correlation between low percentage of 
AI and longer survival (P _ 0.01). No recurrent AIs at specific chromosomal regions were identifiable with 
respect to the primary site. 
Conclusions: The malignant progression of endocrine tumors seems to be associated with complex 
allelotypes and chromosomal instability. Although no specific molecular markers of malignancy can be 
defined with certainty, the ploidy status and the degree of chromosomal derangements appear to be the 
most informative genetic factors with prognostic significance. 
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